Multidisciplinary Program of Treatment of Obesity: Evaluation of Cardiometabolic Risk Factors
- Conditions
- OverweightObesityAbdominal ObesityMorbid ObesityC23.888.144.699C18.654.726.500C18.654.726.500.697C18.654.726.500.700
- Registration Number
- RBR-2yzs76
- Lead Sponsor
- niversidade Estadual de Maringá
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Age between 18 and 50 years; Being overweight or obese, from cutting index points Body mass index greater than or equal 25; Waist circumference greater than or equal 88 cm for women and greater than or equal 102 cm for men; Be resident in Maringa or Maringá metropolitan area; Present willingness to participate in the evaluations of the risk cardiometabólico; Agree and sign the informed consent approved by the local Ethics Committee.
Recent abdominal surgery or Bariatric Surgery;
Pulmonary disease with oxygen dependence; Hospitalization for treatment of cardiovascular diseases in the last 6 months; Aortic stenosis;
Being pregnant or have less than 3 months post partum; Use of medicines for weight loss; Using glicocorticoides;
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome 1 provided for this study will be anthropometric parameters (body weight, BMI and waist circumference).;The primary outcome 2 planned for the present study will be parameters of body composition (fat mass, fat%, fat free mass, fat free mass%).
- Secondary Outcome Measures
Name Time Method The secondary outcome 1 provided for this study will be the metabolic changes (blood glucose, glycated hemoglobin, insulinemia and lipid profile).;The secondary outcome 2 planned for the present study is physical fitness (flexibility, strength/muscular endurance and cardio-respiratory fitness).;The secondary outcome 3 provided for this study will be the inflammatory parameter measured by C-reactive protein ultra sensible.;The secondary outcome 4 referred to the present study are the cardiovascular parameters (heart rate variability, systolic and diastolic blood pressure, carotid intimal middle layer and cardiac geometry).;The secondary outcome 5 scheduled for the present study is the change in lifestyle measured by assessment instruments<br>readiness for change, quality of life, physical activity level and eating habits.